Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
Vaccines · 14.03.2023 · 11 (3) · 658
DOI: 10.3390/vaccines11030658 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 14.03.2023. Verfasst von K Swetha und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Indian Institute of Science Education and Research, Thiruvananthapuram 695551, India. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Science and Engineering Research Board, Science and Engineering Research Board (SERB), India.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for COVID-19 vaccine delivery. LNPs comprise four different lipids: ionizable lipids, helper or neutral lipids, cholesterol, and lipids attached to polyethylene glycol (PEG). In this review, we present recent the advances and insights for the design of LNPs, as well as their composition and properties, with a subsequent discussion on the development of COVID-19 vaccines. In particular, as ionizable lipids are the most critical drivers for complexing the mRNA and in vivo delivery, the role of ionizable lipids in mRNA vaccines is discussed in detail. Furthermore, the use of LNPs as effective delivery vehicles for vaccination, genome editing, and protein replacement therapy is explained. Finally, expert opinion on LNPs for mRNA vaccines is discussed, which may address future challenges in developing mRNA vaccines using highly efficient LNPs based on a novel set of ionizable lipids. Developing highly efficient mRNA delivery systems for vaccines with improved safety against some severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants remains difficult.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemistry, Indian Institute of Science Education and Research, Thiruvananthapuram 695551, India.
- Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
- Centre for Advanced Materials and Industrial Chemistry (CAMIC), School of Science, RMIT University, Melbourne, VIC 3001, Australia.
- Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
- Institute for Human Infections & Immunity, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
ORCID-Profile: Lakshmi Tunki, Suresh K Bhargava, Srinivasa Reddy Bonam, Rajendra Kurapati
Förderung
- Department of Biotechnology
- Science and Engineering Research Board
- Science and Engineering Research Board (SERB), India
- Department of Biotechnology (DBT), India
Zitieren
APA
Swetha, K., Kotla, N. G., Tunki, L., Jayaraj, A., Bhargava, S. K., Hu, H., Bonam, S. R., & Kurapati, R. (2023). Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines. Vaccines, 11(3), 658. https://doi.org/10.3390/vaccines11030658
Vancouver
Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu H, et al. Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines. Vaccines. 2023;11(3):658. doi:10.3390/vaccines11030658
BibTeX
@article{Swetha2023,
author = {Swetha, K and Kotla, Niranjan G and Tunki, Lakshmi and Jayaraj, Arya and Bhargava, Suresh K and Hu, Haitao and Bonam, Srinivasa Reddy and Kurapati, Rajendra},
title = {Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {3},
pages = {658},
doi = {10.3390/vaccines11030658}
}
EUVIMED